GRANDPHARMA

512
4.3400.58% ( +0.025 )
Delay Closed: Nov 16, 16:08:11

Financials

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: GRANDPHARMA(00512) the Revenue is 3.194 B (+3.23%);the EBIT is 581.07 M (-5.79%);the EPS is 0.152 (-11.03%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
3.19B3.23%
----
----
EBIT
0.58B5.79%
----
----
EPS
0.151611.03%
----
----

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly